COMPOUNDS INHIBITING LEUCINE-RICH REPEAT KINASE ENZYME ACTIVITY

The present invention is directed to indazole compounds which are potent inhibitors of LRRK2 kinase and useful in the treatment or prevention of diseases in which the LRRK2 kinase is involved, such as Parkinson's Disease. The invention is also directed to pharmaceutical compositions comprising...

Full description

Saved in:
Bibliographic Details
Main Authors TEMPEST, PAUL, DAI, XING, BASU, KALLOL, SCOTT, JACK, LIU, HONG, DEMONG, DUANE, STAMFORD, ANDREW, POIRIER, MARC, MILLER, MICHAEL
Format Patent
LanguageEnglish
French
Published 12.09.2014
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention is directed to indazole compounds which are potent inhibitors of LRRK2 kinase and useful in the treatment or prevention of diseases in which the LRRK2 kinase is involved, such as Parkinson's Disease. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which LRRK2 kinase is involved. La présente invention concerne des composés indazole, lesquels sont de puissants inhibiteurs de la kinase LRRK2 et sont utiles pour traiter ou prévenir des maladies dans lesquelles la kinase LRRK2 est impliquée, par exemple, la maladie de Parkinson. Cette invention concerne également des compositions pharmaceutiques contenant ces composés, et l'utilisation de ces composés et compositions pour prévenir ou traiter les maladies dans lesquelles la kinase LRRK2 est impliquée.
Bibliography:Application Number: WO2014US18895